Metastatic Breast Cancer Progression Study

Open Research Studies
August 17, 2016

An LBBC industry partner is holding a focus group for people diagnosed with metastatic breast cancer that is either HER2-positive or HER2-negative and who have had a progression of their disease within the last 1-3 years.

The focus group will take place Thursday, September 22nd from 1:00 pm – 4:00 pm at the Loews Philadelphia Hotel. Transportation costs and overnight accommodation, if needed, will be covered. Food will be available.

A professional facilitator will lead participants through a series of questions about conversations between people in treatment and their healthcare providers at the point when a treatment change is needed. The goal is to gain insights on the patients perspectives on information, sensitivity, shared treatment decisions and caregiver’s involvement.

Participants will receive $112.50 for their participation in the focus group.  Apply today to see if you are eligible.

More In Metastatic

Article April 19, 2018
Blog Stories August 23, 2017
Additional Related Topics 
HER2-Positive